IT8748698A0 - Composizione farmaceutica contenente ranitidina - Google Patents

Composizione farmaceutica contenente ranitidina

Info

Publication number
IT8748698A0
IT8748698A0 IT8748698A IT4869887A IT8748698A0 IT 8748698 A0 IT8748698 A0 IT 8748698A0 IT 8748698 A IT8748698 A IT 8748698A IT 4869887 A IT4869887 A IT 4869887A IT 8748698 A0 IT8748698 A0 IT 8748698A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
composition containing
containing ranitidine
ranitidine
pharmaceutical
Prior art date
Application number
IT8748698A
Other languages
English (en)
Other versions
IT1211967B (it
Inventor
Long David Richard
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10608930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8748698(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8748698A0 publication Critical patent/IT8748698A0/it
Application granted granted Critical
Publication of IT1211967B publication Critical patent/IT1211967B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
IT8748698A 1986-12-12 1987-12-11 Composizione farmaceutica contenente ranitidina IT1211967B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629781A GB8629781D0 (en) 1986-12-12 1986-12-12 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IT8748698A0 true IT8748698A0 (it) 1987-12-11
IT1211967B IT1211967B (it) 1989-11-08

Family

ID=10608930

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8748698A IT1211967B (it) 1986-12-12 1987-12-11 Composizione farmaceutica contenente ranitidina

Country Status (23)

Country Link
US (1) US5068249A (it)
JP (1) JP2590156B2 (it)
KR (1) KR960008228B1 (it)
AT (1) AT395373B (it)
AU (1) AU607451B2 (it)
BE (1) BE1000624A5 (it)
CA (1) CA1303993C (it)
CH (1) CH675207A5 (it)
CZ (1) CZ281599B6 (it)
DE (1) DE3742127C2 (it)
DK (1) DK167842B1 (it)
FR (1) FR2608921B1 (it)
GB (2) GB8629781D0 (it)
HK (1) HK19095A (it)
IE (1) IE60618B1 (it)
IL (1) IL84795A0 (it)
IT (1) IT1211967B (it)
NL (1) NL194431C (it)
NZ (1) NZ222879A (it)
PH (1) PH25390A (it)
SE (1) SE504333C2 (it)
YU (1) YU46561B (it)
ZA (1) ZA879338B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL114464A0 (en) * 1994-07-06 1995-11-27 Farmarc Nederland Bv Inclusion complexes of ranitidine
HU213598B (en) * 1994-10-18 1997-08-28 Ge Lighting Tungsram Rt One-side socketed discharge lamp
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
GB9715423D0 (en) 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CA2658465C (en) 2006-07-21 2016-06-14 Stephen C. Tarallo Liquid compositions of calcium acetate
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (de) * 1977-08-06 1979-02-15 Sandoz Ag Stabile loesungen und verfahren zu deren herstellung
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3108753A1 (de) * 1981-03-07 1982-09-16 Degussa Ag, 6000 Frankfurt Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
BE896711A (fr) * 1982-05-14 1983-09-01 Richter Gedeon Vegyeszet Compositions pharmaceutiques anti-ulceres.
JPS59101478A (ja) * 1982-11-29 1984-06-12 Sunstar Inc リグスチライドを安定に配合した水系組成物
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer

Also Published As

Publication number Publication date
IE873367L (en) 1988-06-12
NL8703000A (nl) 1988-07-01
DE3742127A1 (de) 1988-10-06
ATA327387A (de) 1992-05-15
DE3742127C2 (de) 1997-08-28
YU224587A (en) 1990-10-31
DK652787A (da) 1988-06-13
BE1000624A5 (fr) 1989-02-21
KR880007060A (ko) 1988-08-26
JP2590156B2 (ja) 1997-03-12
SE504333C2 (sv) 1997-01-13
YU46561B (sh) 1993-11-16
IT1211967B (it) 1989-11-08
NL194431B (nl) 2001-12-03
PH25390A (en) 1991-06-03
AT395373B (de) 1992-12-10
GB8629781D0 (en) 1987-01-21
AU8244487A (en) 1988-06-16
CA1303993C (en) 1992-06-23
CZ281599B6 (cs) 1996-11-13
SE8704952L (sv) 1988-06-13
ZA879338B (en) 1989-02-22
DK167842B1 (da) 1993-12-27
JPS63215622A (ja) 1988-09-08
NZ222879A (en) 1990-08-28
CH675207A5 (it) 1990-09-14
GB2198352B (en) 1990-11-28
DK652787D0 (da) 1987-12-11
HK19095A (en) 1995-02-17
SE8704952D0 (sv) 1987-12-11
CS403791A3 (en) 1992-08-12
KR960008228B1 (ko) 1996-06-21
GB8728957D0 (en) 1988-01-27
AU607451B2 (en) 1991-03-07
GB2198352A (en) 1988-06-15
IE60618B1 (en) 1994-07-27
US5068249A (en) 1991-11-26
FR2608921A1 (fr) 1988-07-01
FR2608921B1 (fr) 1991-04-12
IL84795A0 (en) 1988-05-31
NL194431C (nl) 2002-04-04

Similar Documents

Publication Publication Date Title
IT1232677B (it) Composizione farmaceutica contenente ranitidina
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DK481585D0 (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
IT1222104B (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina
IT1222103B (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina
FI872733A (fi) Farmaceutiska kompositioner.
IT1211967B (it) Composizione farmaceutica contenente ranitidina
FI872313A (fi) Farmaceutiska kompositioner.
MC1878A1 (fr) Compositions pharmaceutiques
FR2598617B1 (fr) Composition pharmaceutique
FI874414A (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
DK652687D0 (da) Farmaceutisk sammensaetning omfattende azumolen
IT1216814B (it) Composizioni farmaceutiche
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DK624587D0 (da) Farmaceutisk praeparat indeholdende imidazolderivater
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK428287A (da) Nasalt farmaceutisk praeparat
IT8619483A0 (it) Composizioni farmaceutiche.
ATE51150T1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
SE8700576D0 (sv) Pharmaceutical composition
SE8705100D0 (sv) Farmaceutisk komposition
ATE86482T1 (de) Mikrokapseln enthaltende pharmazeutische zusammensetzungen.
SE8603912D0 (sv) Farmaceutisk beredning

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227